Association Between Preoperative Magnetic Resonance Imaging–based Urethral Parameters and Continence Recovery Following Robot-assisted Radical Prostatectomy
Sparing androgen-deprivation therapy upon treatment with abiraterone in patients with chemotherapy-naive castration-resistant prostate cancer: Results from the SPARE-trial (NCT02077634)
Are we improving functional outcomes of prostate cancer patients treated with robot-assisted radical prostatectomy? A 10-year analysis in men treated at two high volume, tertiary referral centers
Overall survival with abiraterone acetate plus prednisone vs. docetaxel for the treatment of metastatic hormone-sensitive prostate cancer: An updated network meta-analysis
Added value of concomitant systematic biopsies in predicting upgrading in patients with localized prostate cancer diagnosed by MRI-targeted biopsy: Implications for treatment selection
Outcomes of primary lymph node staging of intermediate and high risk prostate cancer with 68Ga-PSMA positron emission tomography/computerized tomography compared to histological correlation of pelvic lymph node pathology: can preoperative 68Ga-PSMA positron emission tomography/computerized tomography replace pelvic lymph node dissection for prostate cancer staging?
Effect of adding docetaxel to androgen-deprivation therapy in patients with high-risk prostate cancer with rising prostate-specific antigen levels after primary local therapy: A randomized clinical trial
Head-to-head comparison of TRUS prostate biopsy vs multiparametric prostate resonance imaging with subsequent MR-guided biopsy in biopsy-naïve men with elevated prostate-specific antigen: A large prospective multicenter clinical study